SPINRAZA Copay Program

Eligible commercially insured patients may lower their out-of-pocket costs to as low as $0.

During participation in the program, assistance provided by Biogen will not exceed an individual annual cap, which is based on certain factors, including but not limited to, insurance coverage, claim details, and/or participation in other insurance plan-sponsored programs. Once this cap is reached, you will be responsible for paying 100% of your total copay amount. By completing this form, you will be screened for eligibility in the SPINRAZA Drug Copay and/or Administration Copay Program.

Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, Veterans Affairs (VA), Department of Defense (DoD), or any other federal plans are not eligible to enroll. You are eligible to enroll in the Biogen Copay Program for as long as it is offered and as long as you are treated with SPINRAZA, provided that you meet the eligibility criteria.

;

Patient Eligibility

  • 1
  • 2
  • 3
  • 4

Please answer all questions and click "SUBMIT" to continue.

Please provide State.

*TRICARE® is a registered trademark of the Department of Defense; Defense Health Agency. All rights reserved.

Patient Information

  • 1
  • 2
  • 3
  • 4

Please answer all questions and click "SUBMIT" to continue.

Please provide First Name.
Please provide Last Name.
Please provide Date of Birth.
Please provide Gender.
Please provide Address.
Please provide City.
Please provide State.
Please provide Zip Code.
Please provide Patient Home Phone Number.
Please provide Patient Cell Phone Number.
Please provide email address.
Please select a response.

Your registration is almost finished!

  • 1
  • 2
  • 3
  • 4

In order to allow Biogen to provide you with support services,
please complete the patient authorization below.

I. Authorization to Share Health Information

I understand that I have certain rights related to the collection, use, and disclosure of [my/my child’s] medical and health information. This information is called “protected health information” (PHI) and includes demographic information (such as sex, race, date of birth, etc.), the results of physical examinations, clinical tests, blood tests, X-rays, and other diagnostic medical procedures that may be included in [my/my child’s] medical records. Biogen will not use [my/my child’s] PHI without my consent.

By signing this Authorization, I authorize [my/my child’s] healthcare provider, [my/my child’s] health insurance company and [my/my child’s] pharmacy providers (“Healthcare Entities”) to disclose to Biogen, and companies working with Biogen (collectively, “Biogen”), health information relating to [my/my child’s] medical condition, treatment, and insurance coverage for Biogen to (i) provide [me/my child] with support services (and related information and materials) related to any of Biogen’s products, including but not limited to, online support, financial assistance services, compliance and persistency and other therapy support services, and (ii) conduct data analysis, market research and other necessary internal business activities, and (iii) provide me with information about Biogen’s products, services, and programs for educational or other purposes. I understand that once I sign this Authorization, and [my/my child’s] medical and health information is disclosed to Biogen by the Healthcare Entities, the Health Insurance Portability and Accountability Act (HIPAA) will no longer protect my information because Biogen is not covered by HIPAA. However, Biogen agrees to protect [my/my child’s] health information by using and disclosing it only for purposes authorized in this Authorization or as required by law or regulations. I understand that [my/my child’s] pharmacy provider may receive remuneration from Biogen in exchange for the health information and/or for any therapy support services provided to [me/my child].

I understand that I may refuse to sign this Authorization. I further understand that [my/my child’s] treatment (including with a Biogen product), payment for treatment, insurance enrollment or eligibility for insurance benefits are not conditioned upon my agreement to sign this Authorization; but if I do not sign it or later cancel it, [I/my child] will not be able to receive Biogen’s therapy support services.

I may cancel this Authorization at any time by mailing a letter to: Biogen, ATTN: Patient Services, 5000 Davis Drive, Morrisville, NC, 27560 or emailing privacy@biogen.com. Canceling this Authorization will end consent to further disclosure of [my/my child’s] health information to Biogen by [my/my child’s] Healthcare Entities after they are notified of my cancellation but will not affect previous disclosures by them pursuant to this Authorization. Canceling this authorization will not affect [my/my child’s] ability to receive treatment, payment for treatment, or [my/my child’s] eligibility for health insurance.

This Authorization expires ten (10) years, or such shorter timeframe required by applicable law, from the day I sign it as indicated by the date next to my signature unless otherwise canceled earlier as set forth above.

I have read and understand the Authorization to Share Health Information and agree to the terms.

Please type your name below to provide your signature to authorize the consent:
(If the patient is a minor and you are the patient's Parent/Legal Guardian, please type in your name.)

Enter first name.
Enter last name.
First and last name do not match what was entered in the Patient Information section.

II. Patient Services Authorization

By signing this Authorization, I authorize Biogen, and companies working with Biogen, to provide [me/my child] with support services related to any of Biogen’s products, including but not limited to: online support, financial assistance services, compliance and persistency and other therapy support services, as well as any information or materials related to such services. I understand and agree that personnel, including but not limited to nurses, providing such support services on behalf of Biogen are not employed by [my/my child’s] healthcare professional. I authorize Biogen, and companies working with Biogen, to contact me to provide such services and information by mail, email, fax, telephone call, text message (including calls and text messages made with an automatic telephone dialing system or a prerecorded voice), chat, push notifications and other forms of electronic messaging.

I also authorize Biogen, and companies working with Biogen, to use and disclose [my/my child’s] medical and health information in connection with providing the services, including but not limited to, disclosing [my/my child’s] information to vendors, processors, and service providers for business purposes associated with providing the services, sharing such information with [my/my child’s] healthcare provider, insurance provider, or pharmacy, or disclosing [my/my child’s] information where required by applicable laws or regulations. I also authorize the disclosure of [my/my child’s] health information to specific individuals that I have designated.

I have read and understand the Patient Services Authorization and agree to the terms

Please type your name below to provide your signature to authorize the consent:
(If the patient is a minor and you are the patient's Parent/Legal Guardian, please type in your name.)

Enter first name.
Enter last name.
First and last name do not match what was entered in the Patient Information section.

III. Marketing Authorization

By checking the “Agree to terms” box, I authorize Biogen, and companies working with Biogen, to contact me by mobile or online digital media, mail, email, fax, telephone call, and text message (including autodialed and prerecorded calls and messages) for marketing purposes or otherwise provide me with information about Biogen’s products, services, and programs or other topics of interest, conduct market research or otherwise ask me about [my/my child’s] experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Biogen for marketing, including targeted online marketing, as well as to develop new products, services, and programs. I understand that Biogen will not sell or transfer [my/my child’s] personal data to any unrelated third party for marketing purposes without my express permission. I understand that my consent is not required as a condition of purchasing or receiving any goods or services from Biogen. I understand that I may revoke this authorization and choose not to receive information from Biogen by sending an email with the subject “Unsubscribe” to privacy@biogen.com, or mailing a letter to Biogen, 5000 Davis Drive, Morrisville, NC 27560. For more information visit biogen.com/privacy.

  • Home Phone : 
  • Mobile Phone : 
  • Email : 

Residents of certain US States (including but not limited to California) may have additional rights regarding the collection, use, maintenance, disclosure, and deletion of your personal information. To understand or exercise those rights California residents please visit https://www.biogen.com/privacy-center.html.

I understand that I have the right to receive a copy of the terms and conditions of my agreement with Biogen, and that I may request that copy at the time of signing or at a later date by contacting Biogen at: Biogen, ATTN: Patient Services, 5000 Davis Drive, Morrisville, NC, 27560 or emailing privacy@biogen.com.



Please choose an option to receive your one-time verification code that you need to enter later to complete the enrollment.

Make selection.

Terms and Conditions — SPINRAZA® (nusinersen)

By using the SPINRAZA® (nusinersen) Drug Copay Program and/or the SPINRAZA® (nusinersen) Administration Copay Program, the patient acknowledges and confirms that, at the time of usage, they are currently eligible and meet the criteria set forth in the terms and conditions described below.

The SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program is/are valid ONLY for patients with commercial insurance coverage who have a valid prescription in accordance with the FDA-approved Prescribing Information for SPINRAZA. The patient must have a US prescriber and a US shipping address or administration site. The patient must be a US resident or US citizen. If the claim for SPINRAZA and/or its administration (for which the patient is seeking copay assistance) is reimbursed, either in whole or in part, by a federally funded insurance plan, such as Medicare, Medicaid, VA, Tricare*, or DoD insurance coverage, then the patient is not eligible for assistance through the Biogen Copay Program for SPINRAZA. If the patient obtains a federally funded plan, such as Medicare, Medicaid, VA, TRICARE, or Department of Defense (DoD), at any time during the enrollment period, the patient/caregiver must notify Biogen immediately, and Biogen may be required to stop copay payments and immediately remove the patient from the SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program.

The SPINRAZA Drug Copay Program covers only the cost of the drug and does not cover copays related to administration, office visits, or any network penalties levied by patients' insurance. The SPINRAZA Administration Copay Program only covers eligible costs associated with the administration of SPINRAZA.

The SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program is/are not valid if the costs are eligible to be reimbursed in their entirety by private insurance or other programs. The SPINRAZA Administration Copay Program is not offered to patients who are residents of or receive treatment in Massachusetts or Rhode Island.

These programs are not health insurance or benefit plans. The programs do not obligate the use of a specific product or provider.

Biogen will not provide copay assistance directly to the patient. All program claims will be paid directly to the patient’s administration site or pharmacy upon receipt of appropriate claim submission. The patient’s pharmacy or administration site will be responsible for submitting claims directly to the SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program.

All patients are responsible for appropriately reporting enrollment into the SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program as required by their insurer. It is the patient’s responsibility to ensure compliance with all terms of their insurance as outlined by their insurance plan.

Eighteen (18) months of inactivity may result in removal from the SPINRAZA Drug Copay Program and/or the SPINRAZA Administration Copay Program.

Biogen reserves the right to modify or discontinue this program with respect to any patient, or in its entirety, at any time. Patient participation does not mean that the patient is entitled to receive assistance indefinitely.

*TRICARE is a registered trademark of the Department of Defense; Defense Health Agency. All rights reserved.

WHAT IS SPINRAZA?

SPINRAZA® (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.

IMPORTANT SAFETY INFORMATION

Increased risk of bleeding complications has been observed after administration of similar medicines. Your healthcare provider should perform blood tests before you start treatment with SPINRAZA and before each dose to monitor for signs of these risks. Seek medical attention if unexpected bleeding occurs.

Increased risk of kidney damage, including potentially fatal acute inflammation of the kidney, has been observed after administration of similar medicines. Your healthcare provider should perform urine testing before you start treatment with SPINRAZA and before each dose to monitor for signs of this risk.

The most common side effects of SPINRAZA include lower respiratory infection, fever, constipation, headache, vomiting, back pain, and post-lumbar puncture syndrome.

These are not all of the possible side effects of SPINRAZA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking SPINRAZA, tell your healthcare provider if you are pregnant or plan to become pregnant.

Please see full Prescribing Information.

This information is not intended to replace discussions with your healthcare provider.

©2026 Biogen. All rights reserved. 04/25 FPS-US-0272 v6

This site is intended for residents 18 years or older of the United States, Puerto Rico, and US territories.

All trademarks are the property of their respective owners.

Biogen Logo

©2026 Biogen. All rights reserved. 04/25 FPS-US-0273 v6

This site is intended for residents 18 years or older of the United States, Puerto Rico, and US territories.

All trademarks are the property of their respective owners.

IMPORTANT SAFETY INFORMATION AND INDICATION

WHAT IS SPINRAZA?

SPINRAZA® (nusinersen) is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.

IMPORTANT SAFETY INFORMATION

Increased risk of bleeding complications has been observed after administration of similar medicines. Your healthcare provider should perform blood tests before you start treatment with SPINRAZA and before each dose to monitor for signs of these risks. Seek medical attention if unexpected bleeding occurs.

{"crx-wl-channel":"web","surveyDescription":"Survey1","surveyName":"Survey1","resolveEnrollmentSearchFields":{"patient.firstName":{},"patient.lastName":{},"patient.gender":{},"patient.dob":{},"patient.postalCode":{}},"verifyOtp":true,"maxResendLimit":"3","otpCommunicationType":"both","otpEnrollmentStatus":"rejected","otpValidTime":"15","otpValidUnit":"minutes","emailCommunication":{"emailTemplateId":"Biogen_OTPTemplate","emailAssetId":"8aba3099-9b3b-e911-80c8-005056a96666.html","emailFrom":"no-reply@connectiverx.com","emailTo":"","emailSubject":"Biogen Copay Program Temporary Verification Code","emailFormFields":[{"Id":"OTP","Font":null,"FontSize":null,"Text":"000000"}]},"smsCommunication":{"application":"000000"}}